Brainstorm Cell Therapeutics Inc.’s Q3 2026 10-Q window runs Nov 12, 2026 to Nov 17, 2026.
Based on 8 prior 10-Q filings.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR